Fentanyl Citrate News

Cephalon Presents Positive Results for FENTORA(R) in Breakthrough ... - PR Newswire (press release)

... of fentanyl in FENTORA, when converting patients from other oral fentanyl products, including oral transmucosal fentanyl citrate (OTFC and Actiq(R)), ...

http://www.prnewswire.com/cgi-bin... | Posted: Tue May 01 08:42:01 -0400 2007

Barr Pharmaceuticals - Briefing.com

Additionally, Barr experienced strong sales of Fentanyl Citrate, a generic version of ACTIQ launched in September, along with higher generic oral ...

http://news.briefing.com/GeneralC... | Posted: Wed May 09 11:57:40 -0400 2007

Barr Reports First Quarter 2007 GAAP Earnings of $0.11 Per Share ... - PR Newswire (press release)

all 15 news articles

Posted: Wed May 09 21:24:38 -0400 2007

Barr's 1st-qtr 2007 EPS falls to $0.11 from $0.70 - Therapeutics Daily (subscription) (press release)

US generic products earned $304.0 million versus $200.0 million, due to the inclusion of sales from Pliva, as well as strong sales of fentanyl citrate, ...

http://www.therapeuticsdaily.com/... | Posted: Fri May 11 10:15:00 -0400 2007

Archimedes Pharma Announces Entry of ChiSys®-Based Intranasal ... - Oxfordshire Bioscience Network (press release)

Our own lead product, Nasalfent for the treatment of breakthrough cancer pain, uses PecSys to optimise nasal delivery of fentanyl citrate and recently ...

http://www.oxfordshirebioscience.... | Posted: Fri Apr 13 03:48:38 -0400 2007